CNs enriched in tumor and dendritic cells (CN-5, purple region; Fig. 3f) and tumor and CD4+ T cells (CN-8, yellow region; Fig. 3g) were present at significantly higher frequencies in responders post-treatment compared to other groups. This evidence concerns the gene CD4 and neoplasm.